Bio-AMD Inc. | 2013 | FY | 3


Development stage entity

The Company is considered to be a development stage entity, as defined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 915. The Company has not generated any revenues to date, has incurred significant expenses and has sustained recurring losses. Consequently, its operations are subject to all the risks inherent in the establishment of a new business enterprise. For the period from March 10, 2006 (date of inception) through December 31, 2013, the Company has accumulated deficit of $39,510,727 (of which $30,541,871 has been incurred by the discontinued operations).

us-gaap:DevelopmentStageEnterpriseGeneralDisclosuresTextBlock